Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA2A | P29274 | 1/20 | 0.37 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.37 |
| ▸ | MAP3K8 | P41279 | 3/20 | 0.35 |
| ▸ | GPR3 | P46089 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.34 |
| ▸ | ABCG2 | Q9UNQ0 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | HPGD | P15428 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.33 |
| ▸ | WEE1 | P30291 | 1/20 | 0.33 |
| ▸ | F9 | P00740 | 1/20 | 0.33 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.33 |
| ▸ | ATM | Q13315 | 2/20 | 0.33 |
| ▸ | USP2 | O75604 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22276547 | 0.99 | ADORA2A (0.38) | ADORA2AADORA1MAP3K8GPR3L3MBTL1 | |
| SCHEMBL31625319 | 0.91 | NR1I3 (0.43) | ADORA2AADORA1ABCG2MEN1MAPT | |
| SCHEMBL27253566 | 0.91 | PIM3 (0.39) | ADORA2AADORA1MAP3K8MEN1ALDH1A1 | |
| SCHEMBL24759069 | 0.90 | MEN1 (0.39) | ADORA2AADORA1GPR3L3MBTL1ABCG2 | |
| SCHEMBL20064193 | 0.89 | F9 (0.40) | ADORA2AADORA1MAP3K8GPR3L3MBTL1 | |
| SCHEMBL22879774 | 0.88 | F9 (0.41) | ADORA2AADORA1GPR3L3MBTL1ABCG2 | |
| SCHEMBL23312658 | 0.88 | ADORA2A (0.36) | ADORA2AADORA1MAP3K8GPR3L3MBTL1 | |
| SCHEMBL19196590 | 0.87 | LIMK1 (0.40) | ADORA2AADORA1MAP3K8GPR3L3MBTL1 | |
| SCHEMBL22174459 | 0.87 | LIMK1 (0.36) | ADORA2AADORA1MAP3K8L3MBTL1MEN1 | |
| SCHEMBL23268660 | 0.86 | ALOX5 (0.39) | ADORA2AADORA1MAP3K8GPR3L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10741769-B2 | Organic compound, light-emitting element, light-emitting device, electronic device, and lighting device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2020-08-11 | — | — | US | disclosed |
| US-20180108847-A1 | Organic Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2018-04-19 | — | — | US | disclosed |
| US-20180108847-A1 | Organic Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2018-04-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180108847-A1 | Organic Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device | NR2E3, NR0B1, NR2E1 | ADORA2A 1421/4885ADORA1 578/4885MAP3K8 4510/4885 |
| US-10741769-B2 | Organic compound, light-emitting element, light-emitting device, electronic device, and lighting device | NR2E3, NR0B1, NR2E1 | ADORA2A 1421/4885ADORA1 578/4885MAP3K8 4510/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.